Inhibrx, Inc. (NASDAQ:INBX – Get Rating) Director Jon Faiz Kayyem sold 9,500 shares of Inhibrx in…
Tag: Inhibrx
FY2022 EPS Estimates for Inhibrx, Inc. Raised by Jefferies Financial Group (NASDAQ:INBX)
Inhibrx, Inc. (NASDAQ:INBX – Get Rating) – Equity analysts at Jefferies Financial Group have raised their…
Inhibrx (NASDAQ:INBX) Price Target Cut to $46.00 by Analysts at Credit Suisse Group
Inhibrx (NASDAQ:INBX – Get Rating) had slashed its price target from analysts at Credit Suisse Group…
INHIBRX, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
You should read the following discussion and analysis of our financial condition and results of operations…
Inhibrx (NASDAQ:INBX) Shares Down 7.4% After Insider Selling
Shares of Inhibrx, Inc. (NASDAQ:INBX – Get Rating) fell 7.4% on Thursday afternoon on insider selling…
The price target for Inhibrx (NASDAQ:INBX) has been raised to $60.00.
Evercore ISI equity analysts raised their price target for Inhibx (NASDAQ:INBX) in a research note issued…
Inhibrx (NASDAQ:INBX) Price Target Raised to $60.00
Inhibrx (NASDAQ:INBX – Get Rating) The target price was raised from $54.00 to $60.00 by equity…
